Ion Beam Applications SA (IOBCF) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4769331-ion-beam-applications-sa-iobcf-q4-2024-earnings-call-transcript?source=feed_sector_transcripts
Mar 20, 2025 -
0
Ionis Pharma Beats Expectations for Q4
https://www.fool.com/data-news/2025/02/19/ionis-pharma-beats-expectations-for-q4/?source=iedfolrf0000001
Feb 19, 2025 - The biotech outperformed expectations with better-than-expected revenue and a smaller-than-expected loss.
0
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
https://www.zacks.com/stock/news/2332301/biogen-s-phase-ii-iii-sma-study-for-higher-spinraza-dose-meets-goals?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2332301
Sep 05, 2024 - BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.
0